Journal of Small Animal Practice Ветеринария мелких животных

Urinary liver‐type fatty acid‐binding protein in cats with lower urinary tract disease

N. Culha, A. Acar, B. Ulutas, C. Dinler Ay
Wiley · 2026-10-16 · DOI 10.1111/jsap.70212

Аннотация

Objectives The aim of this study was to evaluate urinary liver‐type fatty acid‐binding protein levels in both obstructive and non‐obstructive feline lower urinary tract disease. In addition, urinary liver‐type fatty acid‐binding protein levels were investigated in cats experiencing short‐term (<36 hours) and long‐term (≥36 hours) urethral obstruction. Materials and Methods The study included 32 cats, classified into two main groups: cats with feline lower urinary tract disease ( n = 24) and healthy controls ( n = 8). The feline lower urinary tract disease group was subdivided into obstructive ( n = 16) and non‐obstructive ( n = 8) forms. The obstructive group was further divided based on urethral obstruction duration into short‐term ( n = 8) and long‐term ( n = 8) sub‐subgroups. Serum creatinine, blood urea nitrogen and potassium were measured in blood samples. Urinary liver‐type fatty acid‐binding protein and urinary creatinine concentrations were measured in urine supernatant samples. Urinary liver‐type fatty acid‐binding protein concentrations were indexed to urinary creatinine and expressed as the urinary liver‐type fatty acid‐binding protein/creatinine ratio. Results The mean urinary liver‐type fatty acid‐binding protein/creatinine values of cats with obstructive feline lower urinary tract disease were statistically higher than those in cats with non‐obstructive feline lower urinary tract disease and healthy controls. The difference between the mean urinary liver‐type fatty acid‐binding protein/creatinine values of cats with long‐term and short‐term obstruction was not statistically significant. In addition, moderately positive correlations were calculated between urinary liver‐type fatty acid‐binding protein/creatinine and serum creatinine ( r = .646; P < .001; 95% CI = 0.264 to 0.863) and between urinary liver‐type fatty acid‐binding protein/creatinine and blood urea nitrogen ( r = .549; P < .01; 95% CI = 0.081 to 0.791) in the study population. Clinical Significance This study is the first to report urinary liver‐type fatty acid‐binding protein/creatinine in cats with feline lower urinary tract disease. The findings suggest that urinary liver‐type fatty acid‐binding protein/creatinine may serve as a potential biomarker for identifying post‐renal acute kidney injury in cats with obstructive feline lower urinary tract disease, particularly in long‐term obstructive cases.

Читать у издателя →